Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BBY vs GSK✓SelectedUSD · GSKBBY vs GSK performance historyLatest closeAs of-1.33%11/20
Stock and ETF performance explorer

BBY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+208.6%
GSK return
+97.4%
Excess return
+111.2%
Maximum drawdown
-52.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.3%-0.1%-1.2%-1.3%
7D-5.9%-5.3%-0.5%-4.2%
30D+4.1%-3.7%+7.7%+5.4%
3M+15.5%-7.3%+22.7%+18.3%
6M+64.5%-4.2%+68.7%+66.3%
YTD+52.1%+0.9%+51.3%+50.5%
1Y+39.8%+7.3%+32.6%+35.6%
3Y+66.4%+52.7%+13.7%+38.3%
5Y-9.1%+40.1%-49.2%-23.7%
All+208.6%+97.4%+111.2%+122.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling